title: Clinical characteristics of juvenile systemic sclerosis in Japanese.
authors.forename: Maki
authors.initials: M
authors.lastname: Murata
authors.forename: Shinichi
authors.initials: S
authors.lastname: Sato
authors.forename: Kazuhiro
authors.initials: K
authors.lastname: Komura
authors.forename: Fumiaki
authors.initials: F
authors.lastname: Shirasaki
authors.forename: Minoru
authors.initials: M
authors.lastname: Hasegawa
authors.forename: Kazuhiko
authors.initials: K
authors.lastname: Takehara
mesh_terms: D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D017668:Age of Onset; D001707:Biopsy, Needle; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D015994:Incidence; D007223:Infant; D007564:Japan / Q000453:epidemiology; D008297:Male; D011239:Prednisolone / Q000627:therapeutic use; D018570:Risk Assessment; D012595:Scleroderma, Systemic / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology*; D012720:Severity of Illness Index; D017678:Sex Distribution; D016896:Treatment Outcome
chemical_list: D011239:Prednisolone